# MAGEH1

## Overview
MAGEH1 is a gene that encodes the protein MAGE family member H1, which is part of the melanoma-associated antigen (MAGE) family. This family of proteins is known for its involvement in various cellular processes, including apoptosis and immune response modulation. MAGEH1 is particularly notable for its interactions with other proteins, such as GADD45G, which play a significant role in apoptosis regulation, especially in renal tubular epithelial cells (Shin2021MAGEH1). The expression of MAGEH1 has been linked to several cancers, where it can serve as a prognostic marker. For instance, its expression levels are associated with survival outcomes in gastric, colorectal, and breast cancers, as well as gliomas, where its downregulation correlates with poor prognosis (Li2021Prognostic; Arora2020Downregulation). These characteristics make MAGEH1 a potential target for therapeutic interventions in oncology.

## Clinical Significance
MAGEH1 has been implicated in various cancers due to alterations in its expression levels and interactions. In gastric cancer, high MAGEH1 expression is associated with poor overall survival and post-progression survival, but it correlates with improved outcomes in patients receiving adjuvant 5-fluorouracil therapy, suggesting a role in overcoming drug resistance (Li2021Prognostic). In colorectal and breast cancers, elevated MAGEH1 expression is an independent risk factor for adverse outcomes (Li2021Prognostic).

In glioma, MAGEH1 expression is downregulated, which is linked to poor prognosis and increased immune infiltration. This downregulation is associated with advancing glioma grades and specific histological subtypes, such as astrocytoma (Arora2020Downregulation). MAGEH1 mutations in gliomas can affect its nuclear localization, potentially impacting its function (ErdemEraslan2015Tumorspecific).

In renal tubular cells, MAGEH1 interacts with the GADD45G gene, and its silencing reduces apoptosis and necrosis, indicating a role in cell survival under stress conditions (Shin2021MAGEH1). These findings highlight MAGEH1's potential as a prognostic marker and therapeutic target in various cancers.

## Interactions
MAGEH1, a member of the melanoma-associated antigen family, is known to interact with several proteins, playing a significant role in cellular processes such as apoptosis. In human renal tubular epithelial (HRE) cells, MAGEH1 interacts with the protein GADD45G. This interaction was confirmed through co-immunoprecipitation assays, which demonstrated that MAGEH1 and GADD45G co-precipitate, indicating a physical interaction between the two proteins. The study also showed that these proteins colocalize in the cytoplasm of HRE cells, suggesting a direct interaction that may influence cellular functions (Shin2021MAGEH1).

The interaction between MAGEH1 and GADD45G is particularly significant in the context of apoptosis. MAGEH1 expression is dependent on GADD45G, as evidenced by the downregulation of MAGEH1 in GADD45G knockdown cells. This interaction is implicated in the regulation of apoptosis in renal tubular cells, especially under conditions of nephrotoxic stress induced by agents like cyclosporine A (CsA). The silencing of MAGEH1 leads to decreased apoptosis and necrosis, highlighting its role in cell death pathways mediated by caspase activation (Shin2021MAGEH1). These findings suggest that MAGEH1, through its interaction with GADD45G, may play a crucial role in renal pathophysiology.


## References


1. (Li2021Prognostic) Prognostic Potential of MAGEH1 and Its Correlation with Immune infiltrates in Gastric Cancer. This article has 0 citations.

[2. (Shin2021MAGEH1) Gyu-Tae Shin, Ji Eun Park, and Min-Jeong Lee. Mageh1 interacts with gadd45g and induces renal tubular cell apoptosis. PLOS ONE, 16(11):e0260135, November 2021. URL: http://dx.doi.org/10.1371/journal.pone.0260135, doi:10.1371/journal.pone.0260135. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0260135)

[3. (ErdemEraslan2015Tumorspecific) Lale Erdem-Eraslan, Daphne Heijsman, Maurice de Wit, Andreas Kremer, Andrea Sacchetti, Peter J. van der Spek, Peter A. E. Sillevis Smitt, and Pim J. French. Tumor-specific mutations in low-frequency genes affect their functional properties. Journal of Neuro-Oncology, 122(3):461â€“470, February 2015. URL: http://dx.doi.org/10.1007/s11060-015-1741-1, doi:10.1007/s11060-015-1741-1. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11060-015-1741-1)

[4. (Arora2020Downregulation) Mohit Arora, Sarita Kumari, Jay Singh, Anita Chopra, and Shyam S. Chauhan. Downregulation of brain enriched type 2 mages is associated with immune infiltration and poor prognosis in glioma. Frontiers in Oncology, December 2020. URL: http://dx.doi.org/10.3389/fonc.2020.573378, doi:10.3389/fonc.2020.573378. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2020.573378)